IPC The Hospitalist Stock Hits New 52-Week High (IPCM)
IPC The Hospitalist Company (Nasdaq:IPCM) hit a new 52-week high Friday as it changed hands at $46.70 compared with its previous 52-week high of $46.50. IPC The Hospitalist is currently trading at $46.61 with 7,119 shares changing hands as of 10 a.m.
NEW YORK ( TheStreet) -- IPC The Hospitalist Company (Nasdaq: IPCM) hit a new 52-week high Friday as it traded at $46.70 compared with its previous 52-Week high of $46.50. IPC The Hospitalist is changing hands at $46.61 with 7,119 shares traded as of 10 a.m. ET. Average volume has been 100,800 shares over the past 30 days. IPC The Hospitalist has a market cap of $729.3 million and is part of the health care sector and health services industry. Shares are up 16.4% year to date as of the close of trading on Thursday. IPC The Hospitalist Company, Inc., a physician group practice company, provides hospitalist services in the United States. The company has a P/E ratio of 30.6, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 16.4.
Practice your IPCM trading strategies and win cash in our stock game.
TheStreet Ratings rates IPC The Hospitalist as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and notable return on equity. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. You can view the full IPC The Hospitalist Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center.